RN7SL307P

Across TCGA pan-cancer cohorts, RN7SL307P RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RN7SL307P data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RN7SL307P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL307P expression acts as an unfavorable survival marker, although some lineages such as LAML show a favorable association.

READ, BRCA, and COAD are the cancer types where RN7SL307P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	II,III,IV	0.227	0.844	<.001	84	view →
BRCA	OS	Tertile	All	0.283	0.588	<.001	72	view →
COAD	OS	Tertile	IV	0.175	0.671	.003	72	view →
LUSC	DFS	Tertile	III,IV	0.195	0.675	<.001	54	view →
THCA	DFS	Tertile	III,IV	0.157	0.721	<.001	51	view →
CESC	OS	Tertile	All	0.542	0.808	.006	42	view →
THYM	DFS	Tertile	All	0.075	0.872	<.001	36	view →
UVM	DFS	Tertile	All	0.079	0.746	<.001	36	view →
BLCA	OS	Tertile	IV	0.103	0.605	<.001	36	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
KIRP	DFS	Tertile	IV	0.042	0.404	.028	36	view →
OV	DFS	Tertile	IV	0.197	0.478	.023	30	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

RN7SL307P–READ (OS)

Open the READ breakdown →